Sumitomo Mitsui Trust Group, Inc.
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1475365
CHIYODA-KU, TOKYO, M0
Position in NTLA
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$25,294,642
+$5,584,418 QoQ
Shares Held
1,973,061
-10.0% QoQ
Ownership
1.41%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sumitomo Mitsui Trust Group, Inc. holds $1,209,271,805 across 38 Biotechnology names. NTLA ranks #11 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
614,448 | $274,375,609 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
273,669 | $211,447,616 | |
| 3 | TECH |
BIO-TECHNE Corp
|
2,054,294 | $107,357,404 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,417 | $104,031,152 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
3,825,585 | $91,163,690 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
1,853,875 | $88,188,833 | |
| 7 | INSM |
INSMED Inc
|
501,282 | $81,969,632 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,273,705 | $61,099,628 |
All Filings in NTLA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,294,642 | 1,973,061 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $19,710,224 | 2,192,461 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $40,668,363 | 2,354,856 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $25,056,465 | 2,671,265 | Shares | Defined | 2025-07-31 | |
| 2025-03-31 | $20,088,316 | 2,825,361 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $34,894,450 | 2,992,663 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $64,720,149 | 3,149,399 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $72,907,079 | 3,257,689 | Shares | Defined | 2024-07-19 | |
| 2024-03-31 | $93,515,238 | 3,399,318 | Shares | Defined | 2024-04-19 | |
| 2023-12-31 | $106,061,355 | 3,478,562 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $111,311,727 | 3,520,295 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $138,434,071 | 3,394,656 | Shares | Defined | 2023-07-31 | |
| 2023-03-31 | $116,020,168 | 3,112,964 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $103,832,709 | 2,976,002 | Shares | Defined | 2023-01-30 | |
| 2022-09-30 | $165,861,410 | 2,963,928 | Shares | Defined | 2022-10-21 | |
| 2022-06-30 | $143,951,599 | 2,781,136 | Shares | Defined | 2022-07-26 | |
| 2022-03-31 | $208,727,788 | 2,872,269 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $325,621,490 | 2,753,903 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $321,951,011 | 2,399,933 | Shares | Defined | 2021-10-25 | |
| 2021-06-30 | $506,390,201 | 3,127,603 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $385,809,379 | 4,807,294 | Shares | Defined | 2021-04-30 | |
| 2020-12-31 | $277,677,292 | 5,104,362 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $120,522,818 | 6,062,516 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $130,222,872 | 6,195,189 | Shares | Defined | 2020-07-27 | |
| 2020-03-31 | $86,726,146 | 7,091,263 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||